New combo attack shrinks eye tumors before radiation
NCT ID NCT05893654
First seen Nov 01, 2025 · Last updated May 14, 2026 · Updated 24 times
Summary
This study tests a new way to treat large eye cancers (uveal melanoma). Ten adults with tumors at least 8 mm thick will get chemotherapy injected directly into the eye's blood vessels. A few weeks later, they receive radiation therapy. The goal is to shrink the tumor enough for safe radiation. Doctors will check safety and vision changes over 6 months.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for UVEAL MELANOMA are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Hospital das Clinicas da Faculdade de Medicina de Ribeirao Preto - USP
Ribeirão Preto, São Paulo, 14040-906, Brazil
Conditions
Explore the condition pages connected to this study.